Delivery Order SPE2DB25D3012-SPE2DB25FXAMN
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a $1,485.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized pharmaceutical product...
- The Defense Logistics Agency awarded a $3,714.90 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, indicating this procurement supports military healthcare needs for pain...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for pain management in osteoarthritis, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $2,228.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is a corticosteroid injectable medication used for intra-articular injection to treat osteoarthritis pain, representing part of...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,714.90 on September 25, 2025, for the supply of Zilretta 32 mg vials, with performance completion targeted for October 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a $7,429.80 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Zilretta 32 mg vials, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside contract, awarded on September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Zilretta is a corticosteroid injection used for osteoarthritis pain management, and this order fulfills medical...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAMNDelivery Order
The Defense Logistics Agency awarded a $17,831.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 17, 2025. This non-set-aside contract was competitively awarded on September 25, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized pharmaceutical product supporting military and veteran healthcare needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's position as a major pharmaceutical distributor and critical federal medical procurement vendor is evidenced by its consistent receipt of competitively awarded contracts across multiple therapeutic domains and delivery order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/25/25 |